{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:16:36Z","timestamp":1758816996296},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Eradication of <jats:italic>Helicobacter pylori<\/jats:italic> provides the most effective treatment for gastroduodenal diseases caused by <jats:italic>H. pylori<\/jats:italic> infection. Clarithromycin, a member of the macrolide family, still remains the most important antibiotic used in <jats:italic>H. pylori<\/jats:italic> eradication treatment. But the increasing prevalence of clarithromycin resistant <jats:italic>H. pylori<\/jats:italic> strains due to point mutations in the V region of the 23S rRNA, poses a great threat in treating the ailing patients. So, we aimed for PCR-mediated rapid detection of the point mutation at 2143 position of 23S rRNA gene in <jats:italic>H. pylori<\/jats:italic> that is relevant to clarithromycin resistance from culture and simultaneously from biopsy specimens to avoid the empirical treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Newly developed PCR assay using DNA of pure culture detected point mutation in 23S rRNA gene in 21 (8.04%) of 261 clinical strains tested. The agar dilution method showed that all these 21 strains were resistant to clarithromycin indicating the perfect match of the PCR based results. Additionally, the sequencing study also identified the A to G mutation at 2143 position in 23S rRNA gene of the resistant strains only. Consequently, the newly developed Nested-ASP-PCR dealing directly with 50 biopsy specimens demonstrated 100% sensitivity and specificity with the findings of agar dilution method taken as Gold standard. Bioinformatics based analysis such as accessibility analysis and dot plot clearly stated that the base pairing probability has increased due to mutation. Computational studies revealed that the point mutation confers more stability in secondary structure due to conversion of loop to stem. Furthermore, interaction studies showed binding affinity of the CLR to the mutant type is weaker than that to the wild type.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This assay outlines a rapid, sensitive and simple approach to identify point mutation that confers clarithromycin resistance as well as clarithromycin sensitive strains, providing rapid initiation of effective antibiotic treatment. Additionally, it is simple to adopt for hospital based diagnostic laboratories to evaluate the degree of regional clarithromycin resistance from biopsy specimens itself. Furthermore, in silico studies provide evidence or a signal that the prevalence of clarithromycin resistance may rise in the near future as a result of this point mutation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13099-023-00530-7","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:04:38Z","timestamp":1676343878000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and evaluation of a simple PCR assay and nested PCR for rapid detection of clarithromycin-resistant Helicobacter pylori from culture and directly from the biopsy samples in India"],"prefix":"10.1186","volume":"15","author":[{"given":"Bipul Chandra","family":"Karmakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangita","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surajit","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashree","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujit","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asish Kumar","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"issue":"1","key":"530_CR1","first-page":"26","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26\u201338.","journal-title":"Prz Gastroenterol"},{"issue":"6","key":"530_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"530_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","volume":"22","author":"LM Brown","year":"2000","unstructured":"Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22(2):283\u201397.","journal-title":"Epidemiol Rev"},{"issue":"2","key":"530_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/CMR.00033-06","volume":"20","author":"F Megraud","year":"2007","unstructured":"Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20(2):280\u2013322.","journal-title":"Clin Microbiol Rev"},{"issue":"16","key":"530_CR5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325(16):1127\u201331.","journal-title":"N Engl J Med"},{"issue":"8776","key":"530_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338(8776):1175\u20136.","journal-title":"Lancet"},{"issue":"9201","key":"530_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(99)05143-0","volume":"355","author":"ML Shahinian","year":"2000","unstructured":"Shahinian ML, Passaro DJ, Swerdlow DL, Mintz ED, Rodriguez M, Parsonnet J. Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru. Lancet. 2000;355(9201):377\u20138.","journal-title":"Lancet"},{"issue":"6","key":"530_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1046\/j.1440-1746.2002.02746.x","volume":"17","author":"V Singh","year":"2002","unstructured":"Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 2002;17(6):659\u201365.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"530_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420\u20139.","journal-title":"Gastroenterology"},{"issue":"10","key":"530_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrgastro.2014.99","volume":"11","author":"P Malfertheiner","year":"2014","unstructured":"Malfertheiner P, Link A, Selgrad M. Helicobacter pylori: perspectives and time trends. Nat Rev Gastroenterol Hepatol. 2014;11(10):628\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"530_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02530-16","author":"D Chen","year":"2017","unstructured":"Chen D, Cunningham SA, Cole NC, Kohner PC, Mandrekar JN, Patel R. Phenotypic and molecular antimicrobial susceptibility of Helicobacter pylori. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.02530-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"530_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","volume":"2","author":"YT Kuo","year":"2017","unstructured":"Kuo YT, Liou JM, El-Omar EM, Wu JY, Leow AHR, Goh KL, Das R, Lu H, Lin JT, Tu YK, et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):707\u201315.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"18","key":"530_CR13","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.7314\/APJCP.2015.16.18.8281","volume":"16","author":"T Tongtawee","year":"2015","unstructured":"Tongtawee T, Dechsukhum C, Matrakool L, Panpimanmas S, Loyd RA, Kaewpitoon SJ, Kaewpitoon N. High Prevalence of Helicobacter pylori resistance to clarithromycin: a Hospital-based cross-sectional study in Nakhon Ratchasima Province, Northeast of Thailand. Asian Pac J Cancer Prev. 2015;16(18):8281\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"530_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jac\/dki406","volume":"57","author":"P Posteraro","year":"2006","unstructured":"Posteraro P, Branca G, Sanguinetti M, Ranno S, Cammarota G, Rahimi S, De Carlo M, Posteraro B, Fadda G. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay. J Antimicrob Chemother. 2006;57(1):71\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"530_CR15","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1128\/JB.182.11.3219-3227.2000","volume":"182","author":"AK Mukhopadhyay","year":"2000","unstructured":"Mukhopadhyay AK, Kersulyte D, Jeong JY, Datta S, Ito Y, Chowdhury A, Chowdhury S, Santra A, Bhattacharya SK, Azuma T, et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta. India J Bacteriol. 2000;182(11):3219\u201327.","journal-title":"India J Bacteriol"},{"issue":"Suppl 1","key":"530_CR16","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1136\/gut.43.2008.S61","volume":"43","author":"F Megraud","year":"1998","unstructured":"Megraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut. 1998;43(Suppl 1):S61-65.","journal-title":"Gut"},{"issue":"9","key":"530_CR17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1572-0241.1998.455_t.x","volume":"93","author":"N Vakil","year":"1998","unstructured":"Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol. 1998;93(9):1432\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"530_CR18","first-page":"357","volume":"61","author":"Y Glupczynski","year":"1998","unstructured":"Glupczynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg. 1998;61(3):357\u201366.","journal-title":"Acta Gastroenterol Belg"},{"issue":"6","key":"530_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1046\/j.1365-2036.1997.00258.x","volume":"11","author":"H Miyaji","year":"1997","unstructured":"Miyaji H, Azuma T, Ito S, Suto H, Ito Y, Yamazaki Y, Sato F, Hirai M, Kuriyama M, Kato T, et al. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther. 1997;11(6):1131\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"530_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jac\/37.3.473","volume":"37","author":"HX Xia","year":"1996","unstructured":"Xia HX, Buckley M, Keane CT, O\u2019Morain CA. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother. 1996;37(3):473\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"530_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101275","volume":"24","author":"A Bahadori","year":"2021","unstructured":"Bahadori A, G\u00f6kmen TG, K\u00f6ksal F, Tumgor G, Agin M, Sadighi A, Ziaee M, Rahbarnia L. High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disorders. Gene Rep. 2021;24: 101275.","journal-title":"Gene Rep"},{"issue":"1","key":"530_CR22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41467-021-22557-7","volume":"12","author":"E Kocsmar","year":"2021","unstructured":"Kocsmar E, Buzas GM, Szirtes I, Kocsmar I, Kramer Z, Szijarto A, Fadgyas-Freyler P, Szenas K, Rugge M, Fassan M, et al. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. Nat Commun. 2021;12(1):2255.","journal-title":"Nat Commun"},{"issue":"5","key":"530_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1523-5378.2009.00714.x","volume":"14","author":"N Horiki","year":"2009","unstructured":"Horiki N, Omata F, Uemura M, Suzuki S, Ishii N, Iizuka Y, Fukuda K, Fujita Y, Katsurahara M, Ito T, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter. 2009;14(5):86\u201390.","journal-title":"Helicobacter"},{"issue":"3","key":"530_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/hel.12124","volume":"19","author":"T Okamura","year":"2014","unstructured":"Okamura T, Suga T, Nagaya T, Arakura N, Matsumoto T, Nakayama Y, Tanaka E. Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison. Helicobacter. 2014;19(3):214\u201320.","journal-title":"Helicobacter"},{"issue":"5","key":"530_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1523-5378.2010.00788.x","volume":"15","author":"W Gao","year":"2010","unstructured":"Gao W, Cheng H, Hu F, Li J, Wang L, Yang G, Xu L, Zheng X. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing China. Helicobacter. 2010;15(5):460\u20136.","journal-title":"Helicobacter"},{"issue":"9","key":"530_CR26","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","volume":"21","author":"YX Zhang","year":"2015","unstructured":"Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study. World J Gastroenterol. 2015;21(9):2786\u201392.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"530_CR27","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1128\/AAC.49.4.1600-1603.2005","volume":"49","author":"JH Lee","year":"2005","unstructured":"Lee JH, Shin JH, Roe IH, Sohn SG, Lee JH, Kang GH, Lee HK, Jeong BC, Lee SH. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob Agents Chemother. 2005;49(4):1600\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"530_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MCG.0b013e3181d04592","volume":"44","author":"TJ Hwang","year":"2010","unstructured":"Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, Lee MK, Park YS, Lee DH, Jung HC, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol. 2010;44(8):536\u201343.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"530_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2036.2005.02533.x","volume":"22","author":"S Datta","year":"2005","unstructured":"Datta S, Chattopadhyay S, Patra R, De R, Ramamurthy T, Hembram J, Chowdhury A, Bhattacharya SK, Berg DE, Nair GB, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther. 2005;22(1):51\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"530_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jgar.2015.09.009","volume":"5","author":"V Gehlot","year":"2016","unstructured":"Gehlot V, Mahant S, Mukhopadhyay AK, Das K, De R, Kar P, Das R. Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India. J Glob Antimicrob Resist. 2016;5:51\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"530_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"530_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0924-8579(00)00338-1","volume":"17","author":"S Ioannidou","year":"2001","unstructured":"Ioannidou S, Tassios PT, Kotsovili-Tseleni A, Foustoukou M, Legakis NJ, Vatopoulos A. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. Int J Antimicrob Agents. 2001;17(3):195\u2013201.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"530_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1128\/AAC.40.2.477","volume":"40","author":"J Versalovic","year":"1996","unstructured":"Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996;40(2):477\u201380.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"530_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2003.09.015","volume":"23","author":"NC Elviss","year":"2004","unstructured":"Elviss NC, Lawson AJ, Owen RJ. Application of 3\u02b9-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori. Int J Antimicrob Agents. 2004;23(4):349\u201355.","journal-title":"Int J Antimicrob Agents"},{"key":"530_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/483136","volume":"2014","author":"SK Patel","year":"2014","unstructured":"Patel SK, Mishra GN, Pratap CB, Jain AK, Nath G. Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study. Biomed Res Int. 2014;2014: 483136.","journal-title":"Biomed Res Int"},{"issue":"Pt 9","key":"530_CR36","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1099\/jmm.0.47302-0","volume":"56","author":"N Noguchi","year":"2007","unstructured":"Noguchi N, Rimbara E, Kato A, Tanaka A, Tokunaga K, Kawai T, Takahashi S, Sasatsu M. Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. J Med Microbiol. 2007;56(Pt 9):1174\u201380.","journal-title":"J Med Microbiol"},{"issue":"3","key":"530_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/gut.43.3.317","volume":"43","author":"S Maeda","year":"1998","unstructured":"Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut. 1998;43(3):317\u201321.","journal-title":"Gut"},{"key":"530_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13099-020-00373-6","volume":"12","author":"Y Li","year":"2020","unstructured":"Li Y, Lv T, He C, Wang H, Cram DS, Zhou L, Zhang J, Jiang W. Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin. Gut Pathog. 2020;12:35.","journal-title":"Gut Pathog"},{"issue":"Pt 9","key":"530_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1099\/jmm.0.038398-0","volume":"61","author":"J Alam","year":"2012","unstructured":"Alam J, Maiti S, Ghosh P, De R, Chowdhury A, Das S, Macaden R, Devarbhavi H, Ramamurthy T, Mukhopadhyay AK. Significant association of the dupA gene of Helicobacter pylori with duodenal ulcer development in a South-east Indian population. J Med Microbiol. 2012;61(Pt 9):1295\u2013302.","journal-title":"J Med Microbiol"},{"issue":"7","key":"530_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1046\/j.1365-2036.2000.00795.x","volume":"14","author":"WH Wang","year":"2000","unstructured":"Wang WH, Wong BC, Mukhopadhyay AK, Berg DE, Cho CH, Lai KC, Hu WH, Fung FM, Hui WM, Lam SK. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther. 2000;14(7):901\u201310.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"530_CR41","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1128\/JCM.42.6.2821-2824.2004","volume":"42","author":"S Chattopadhyay","year":"2004","unstructured":"Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A, Santra A, Dhali GK, Bhattacharya SK, Berg DE, Nair GB, Mukhopadhyay AK. Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J Clin Microbiol. 2004;42(6):2821\u20134.","journal-title":"J Clin Microbiol"},{"key":"530_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/0471142700.nc1102s28","author":"DH Mathews","year":"2007","unstructured":"Mathews DH, Turner DH, Zuker M. RNA secondary structure prediction. Curr Protoc Nucleic Acid Chem. 2007. https:\/\/doi.org\/10.1002\/0471142700.nc1102s28.","journal-title":"Curr Protoc Nucleic Acid Chem"},{"issue":"30","key":"530_CR43","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1016\/j.febslet.2007.11.054","volume":"581","author":"S Basak","year":"2007","unstructured":"Basak S, Roy S, Ghosh TC. On the origin of synonymous codon usage divergence between thermophilic and mesophilic prokaryotes. FEBS Lett. 2007;581(30):5825\u201330.","journal-title":"FEBS Lett"},{"issue":"5","key":"530_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/bioinformatics\/btk014","volume":"22","author":"SH Bernhart","year":"2006","unstructured":"Bernhart SH, Hofacker IL, Stadler PF. Local RNA base pairing probabilities in large sequences. Bioinformatics. 2006;22(5):614\u20135.","journal-title":"Bioinformatics"},{"issue":"11","key":"530_CR45","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1093\/nar\/gkx386","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Mao K, Zhao Y, Zeng C, Xiang J, Zhang Y, Xiao Y. Optimization of RNA 3D structure prediction using evolutionary restraints of nucleotide-nucleotide interactions from direct coupling analysis. Nucleic Acids Res. 2017;45(11):6299\u2013309.","journal-title":"Nucleic Acids Res"},{"key":"530_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36:901\u20136.","journal-title":"Nucleic Acids Res"},{"key":"530_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.729513","volume":"8","author":"RV Honorato","year":"2021","unstructured":"Honorato RV, Koukos PI, Jimenez-Garcia B, Tsaregorodtsev A, Verlato M, Giachetti A, Rosato A, Bonvin A. Structural biology in the clouds: the WeNMR-EOSC ecosystem. Front Mol Biosci. 2021;8: 729513.","journal-title":"Front Mol Biosci"},{"key":"530_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13099-017-0186-9","volume":"9","author":"P Mukherjee","year":"2017","unstructured":"Mukherjee P, Dutta S, Mukhopadhyay AK. Development and evaluation of a PCR assay for rapid detection of azithromycin resistant Campylobacter isolated from diarrhoeal patients in Kolkata India. Gut Pathog. 2017;9:37.","journal-title":"Gut Pathog"},{"issue":"7","key":"530_CR49","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1128\/AAC.38.7.1496","volume":"38","author":"RC Goldman","year":"1994","unstructured":"Goldman RC, Zakula D, Flamm R, Beyer J, Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother. 1994;38(7):1496\u2013500.","journal-title":"Antimicrob Agents Chemother"},{"key":"530_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2022.100025","volume":"4","author":"SF Koya","year":"2022","unstructured":"Koya SF, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Consumption of systemic antibiotics in India in 2019. Lancet Regional Health Southeast Asia. 2022;4: 100025.","journal-title":"Lancet Regional Health Southeast Asia"},{"key":"530_CR51","doi-asserted-by":"publisher","DOI":"10.3823\/866","author":"N Dar-Odeh","year":"2022","unstructured":"Dar-Odeh N, Abu-Hammad O, Abu-Hammad S, Eshky R, Abdouh I, Aboelnagga M, Abu-Hammad A. Impact Of COVID-19 pandemic on the pattern of azithromycin prescribing; a review. Int Arabic J Antimicrobial Agents. 2022. https:\/\/doi.org\/10.3823\/866.","journal-title":"Int Arabic J Antimicrobial Agents"},{"issue":"12","key":"530_CR52","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.4103\/jfmpc.jfmpc_812_21","volume":"10","author":"S Atal","year":"2021","unstructured":"Atal S, Misra S, Balakrishnan S. Continued use of azithromycin for mild COVID-19 in India: evidence and implications? J Family Med Prim Care. 2021;10(12):4341\u20134.","journal-title":"J Family Med Prim Care"},{"key":"530_CR53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2147\/IDR.S351827","volume":"15","author":"SMA Abdelmalek","year":"2022","unstructured":"Abdelmalek SMA, Mousa A. Azithromycin misuse during the COVID-19 pandemic: a cross-sectional study from Jordan. Infect Drug Resist. 2022;15:747\u201355.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"530_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14081","volume":"75","author":"AA Elsayed","year":"2021","unstructured":"Elsayed AA, Darwish SF, Zewail MB, Mohammed M, Saeed H, Rabea H. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt. Int J Clin Pract. 2021;75(6): e14081.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"530_CR55","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. Management of Helicobacter pylori infection\u2013the Maastricht IV\/florence consensus report. Gut. 2012;61(5):646\u201364.","journal-title":"Gut"},{"issue":"1","key":"530_CR56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/JCM.40.1.259-261.2002","volume":"40","author":"ZJ Pan","year":"2002","unstructured":"Pan ZJ, Su WW, Tytgat GN, Dankert J, van der Ende A. Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR. J Clin Microbiol. 2002;40(1):259\u201361.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"530_CR57","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/cam4.1986","volume":"8","author":"XY Zhang","year":"2019","unstructured":"Zhang XY, Shen WX, Chen CF, Sheng HH, Cheng H, Li J, Hu F, Lu DR, Gao HJ. Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR. Cancer Med. 2019;8(4):1633\u201340.","journal-title":"Cancer Med"},{"key":"530_CR58","doi-asserted-by":"publisher","first-page":"2304173","DOI":"10.1155\/2020\/2304173","volume":"2020","author":"J Vazirzadeh","year":"2020","unstructured":"Vazirzadeh J, Falahi J, Moghim S, Narimani T, Rafiei R, Karbasizadeh V. Molecular assessment of resistance to clarithromycin in Helicobacter pylori Strains isolated from patients with dyspepsia by fluorescent in situ hybridization in the center of Iran. Biomed Res Int. 2020;2020:2304173.","journal-title":"Biomed Res Int"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-023-00530-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T05:50:39Z","timestamp":1676353839000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-023-00530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1186\/s13099-023-00530-7","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ICMR-NICED Ethical committee had approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"The authors affirm that there were no financial or commercial ties that might be viewed as a potential conflict of interest throughout the execution of the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}